Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CareDx Inc CDNA

Healthcare Biotechnology
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based... see more

Recent & Breaking News (NDAQ:CDNA)

CareDx to Participate in Upcoming Investor Conferences

Business Wire 12 days ago

CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance

Business Wire November 4, 2024

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Accesswire October 25, 2024

CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology

Business Wire October 23, 2024

CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting

Business Wire October 21, 2024

CareDx Reports Preliminary Financial Results for Third Quarter 2024

Business Wire October 15, 2024

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

PR Newswire October 11, 2024

CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 11, 2024

CareDx Appoints Jing Huang Chief Data and AI Officer

Business Wire October 9, 2024

CareDx to Host Investor Day on October 15, 2024

Business Wire October 8, 2024

CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing

Business Wire October 8, 2024

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Accesswire September 30, 2024

CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 13, 2024

CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 13, 2024

CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer

Business Wire September 12, 2024

CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing

Business Wire August 16, 2024

CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance

Business Wire July 31, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA)

PR Newswire July 16, 2024

CareDx to Report Second Quarter 2024 Financial Results

Business Wire July 16, 2024

Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients

Business Wire June 3, 2024